Today we explore the remarkable drug Paxlovid before turning to a new report suggesting we were wrong. The drug now appears not associated with a higher probability of COVID-19 re-infection.

Approximately 15 percent of those with a COVID-19 infection will develop long COVID. Long COVID is prevalent and more common among females and older individuals.

How climate change and human activity are the tipping points for infectious diseases of epidemic proportions

"CLOTH MASKS ARE LITTLE MORE than facial decorations." That's the remarkable statement from CNN Medical Analyst Dr. Leana Wen. She adds: "This is what scientists and...